-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RJ/JBf9/8FOzTqJsfQ8QcAnf8EaKN5rdzhjbjqJHQ3uGdwqcxMfQ61sRVl+FBM9x CQjrd2s8Ln6BVy3cc0Pk0A== 0001096906-05-000077.txt : 20050302 0001096906-05-000077.hdr.sgml : 20050302 20050302134037 ACCESSION NUMBER: 0001096906-05-000077 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050302 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20050302 DATE AS OF CHANGE: 20050302 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UTAH MEDICAL PRODUCTS INC CENTRAL INDEX KEY: 0000706698 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 870342734 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12575 FILM NUMBER: 05653445 BUSINESS ADDRESS: STREET 1: 7043 S 300 WEST CITY: MIDVALE STATE: UT ZIP: 84047 BUSINESS PHONE: 8015661200 8-K 1 utahmed8k030205.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 2, 2005 Commission File No. 0-11178 ------- UTAH MEDICAL PRODUCTS, INC. --------------------------- (Exact name of Registrant as specified in its charter) UTAH 87-0342734 ------------------------------- ------------------ (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 7043 South 300 West Midvale, Utah 84047 --------------------------------------- Address of principal executive offices Registrant's telephone number: (801) 566-1200 -------------- - -------------------------------------------------------------------------------- ITEM 7.01 - REGULATION FD DISCLOSURE - -------------------------------------------------------------------------------- The U.S. Court has granted the government's (FDA's/plaintiff's) Motion for an Extension of Time for Discovery, and modified the Scheduling Order in Case No. 2:04CV00733 BSJ. UTMD is the defendant in this case. All discovery is to be completed by May 2, 2005. This represents a two month extension from the prior schedule. The final pretrial conference is scheduled for June 20, 2005. This represents a five week extension from the prior schedule. Under SEC Fair Disclosure regulations, the Company feels it needs to disseminate this information. - -------------------------------------------------------------------------------- SIGNATURES - -------------------------------------------------------------------------------- Pursuant to the requirements of the Securities Exchanges Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. UTAH MEDICAL PRODUCTS, INC. --------------------------- REGISTRANT Date: 3/02/05 By: \s\ Kevin L. Cornwell ------------------- ------------------------- Kevin L. Cornwell Chairman & CEO -----END PRIVACY-ENHANCED MESSAGE-----